BEWARE APPLES AND ORANGES: SOME BUSINESSES REALLY CANNOT BE BOOTSTRAPPED. These are the R&D intensive ventures like Biopharma and CleanTech, in particular, where a huge windfall of income only (sometimes) comes after years of super-expensive clinical or field studies. It is important not to confuse this with ventures in other fields that actually do earn early (customer) revenues, and in these instances bootstrapping is a real and important option to consider.
http://lnkd.in/csK3p8
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022